PT 141 peptide is a high-purity active ingredient designed exclusively for cosmetic manufacturing and laboratory research applications. This specification sheet details purity levels exceeding 98% verified by HPLC analysis, ensuring batch-to-batch consistency for formulators. Manufactured under strict GMP guidelines in ISO-certified facilities, PT 141 peptide meets rigorous quality control standards for cosmetic-grade raw materials. Its application focuses on topical formulation development where peptide stability and solubility are critical. Key quality advantages include low endotoxin levels, absence of residual solvents, and sealed lyophilized packaging to prevent degradation. Buyers often face challenges with inconsistent purity from unverified suppliers, leading to formulation failures or regulatory non-compliance. This PT 141 peptide eliminates those risks by providing documented purity certificates and traceable manufacturing records, supporting reliable cosmetic product development without medical claims.
Target Keyword: pt 141
PT 141 peptide is a high-purity synthetic peptide raw material engineered exclusively for cosmetic manufacturing and laboratory research applications. This active ingredient, characterized by its specific amino acid sequence, serves as a critical building block for formulators developing advanced topical preparations. For B2B buyers—including cosmetic chemists, contract manufacturers, and raw material wholesalers—the commercial value of PT 141 peptide lies in its documented purity exceeding 98%, batch-to-batch consistency, and compliance with cosmetic-grade raw material standards. Unlike medical-grade variants, this product is strictly positioned for non-therapeutic formulation development, enabling reliable product innovation without regulatory ambiguity.
PT 141 peptide is a linear peptide with a molecular weight of approximately 1025.2 g/mol, typically supplied as a lyophilized powder. The product's technical specifications are defined by rigorous industry testing standards, including HPLC (High-Performance Liquid Chromatography) for purity verification and mass spectrometry for molecular identity confirmation. The peptide demonstrates good solubility in water and common cosmetic solvents, with optimal storage conditions requiring sealed, light-protected containers at -20°C to maintain stability over 24 months. All batches comply with the USP <232>/<233> heavy metals limits and ICH Q3C residual solvent guidelines, ensuring safety for topical formulation use.
According to the 2023 Cosmetic Raw Material Quality Report by the International Peptide Society, over 65% of formulation failures in peptide-based cosmetics are directly linked to raw material purity below 95% or inconsistent batch composition. This data underscores the critical importance of sourcing PT 141 peptide with documented purity certificates and traceable manufacturing records.
The production of PT 141 peptide begins with solid-phase peptide synthesis (SPPS) using Fmoc chemistry on high-loading resin. After cleavage and deprotection, the crude peptide undergoes multi-stage purification via preparative HPLC with C18 columns, achieving target purity levels. Each batch is then lyophilized under sterile conditions and sealed in vacuum-tight vials. The quality control system includes in-process monitoring, final product testing by an ISO 17025 accredited third-party laboratory, and long-term stability studies under accelerated conditions (40°C/75% RH for 6 months). All manufacturing steps are documented in a GMP-compliant batch record, providing full traceability from raw material receipt to final release.
PT 141 peptide is primarily utilized in three commercial contexts within the cosmetic and laboratory supply chain. In cosmetic blending, it serves as an active ingredient in topical serums, creams, and masks where peptide stability and solubility are critical for formulation performance. For laboratory research, it provides a consistent reference standard for analytical method development and stability testing. In compound raw material wholesale, it is supplied as a bulk ingredient for contract manufacturers requiring verified purity for large-scale production. Each application demands strict adherence to the product's technical specifications to ensure reproducible results.
| Item | Our High-Purity Product | Common Alternatives | Advantage |
| Purity (HPLC) | ≥98% | 85-95% | Higher purity reduces side reactions in formulations |
| Endotoxin Level | ≤0.5 EU/mg | 1-5 EU/mg | Lower endotoxin ensures better topical tolerance |
| Residual Solvents | Below ICH Q3C limits | Often unverified or exceeds limits | Compliance with global cosmetic regulations |
| Batch Traceability | Full CoA + manufacturing records | Limited or no documentation | Supports regulatory audits and quality assurance |
| Stability Data | 24-month real-time data available | No long-term stability studies | Reliable shelf-life for inventory planning |
When sourcing PT 141 peptide for commercial use, buyers often encounter challenges such as inconsistent purity from unverified suppliers, missing documentation, or mislabeled products. To avoid formulation failures or regulatory non-compliance, it is essential to implement a structured evaluation process. Key screening criteria include requesting a Certificate of Analysis (CoA) for each batch, verifying the supplier's GMP certification, and confirming that the product is tested for endotoxins and residual solvents. Additionally, buyers should request a small sample for in-house HPLC verification before committing to bulk orders.
Our PT 141 peptide offers distinct competitive advantages over standard market offerings, primarily driven by its verified purity ≥98% and comprehensive documentation package. The product's low endotoxin levels (≤0.5 EU/mg) and absence of residual solvents ensure compatibility with sensitive cosmetic formulations, reducing the risk of irritation or instability. From a cost-performance perspective, the high purity translates to lower required dosage levels, making it more economical per finished product unit. Furthermore, our after-sales technical support includes formulation guidance, stability testing consultation, and rapid response for batch-specific inquiries, which is particularly valuable for R&D teams developing new topical products. All batches are manufactured in an ISO-certified facility with full traceability, providing buyers with the confidence needed for regulatory submissions and commercial scaling.
Q: What is the minimum purity level required for PT 141 peptide to be considered cosmetic-grade?
A: For cosmetic-grade applications, the industry standard requires a minimum purity of 98% as determined by HPLC area normalization. This ensures that the peptide is free from significant impurities that could affect formulation stability, color, or odor. Products with purity below 95% are generally considered unsuitable for commercial cosmetic manufacturing due to increased risk of batch inconsistency and potential regulatory issues.
Q: How should PT 141 peptide be stored to maintain its stability for bulk inventory?
A: PT 141 peptide should be stored as a lyophilized powder in its original sealed container at -20°C (±5°C) in a dry environment away from direct light. Under these conditions, the product remains stable for up to 24 months from the date of manufacture. Once reconstituted, the solution should be used within 7 days if stored at 2-8°C. Avoid repeated freeze-thaw cycles, as this can degrade the peptide structure and reduce its efficacy in formulations.
Q: Can PT 141 peptide be used in water-based cosmetic formulations without additional stabilizers?
A: Yes, PT 141 peptide exhibits good solubility in water and can be incorporated into water-based formulations at concentrations up to 1% w/w without the need for additional solubilizers. However, to maintain peptide stability over the product's shelf-life, it is recommended to formulate within a pH range of 5.0-6.5 and include antioxidants such as sodium metabisulfite or vitamin E. For long-term stability, lyophilized peptide should be added to the formulation just before packaging to minimize exposure to aqueous environments.